Accordingly, TCF7L2 silencing leads to genome-wide changes in chromatin architecture and enhancer-promoter interactions in pancreatic and colon cancer cells, whilst TCF-bound Wnt responsive enhancers regulate chromatin looping and activation of the Myc gene in colorectal cancer [37–39]. Here, TCF7L2 is linked to colorectal cancer.